Literature DB >> 1898970

Immunogenic peptides of influenza virus subtype N1 neuraminidase identify a T-cell determinant used in class II major histocompatibility complex-restricted responses to infectious virus.

C J Hackett1, D Horowitz, M Wysocka, L C Eisenlohr.   

Abstract

Six nonoverlapping peptides of the neuraminidase (NA) glycoprotein of influenza virus A/Puerto Rico/8/34 (H1N1) (PR8 virus) were found to be immunogenic for proliferating T cells when injected into BALB/c mice in Freund adjuvant. T cells elicited by peptide immunization could recognize PR8 virus in vitro. However, only one of these peptides, corresponding to residues 79 to 93 of NA (NA 79-93), was able to restimulate T cells of mice immunized with infectious virus. T cells that recognized this peptide were uniformly I-Ed restricted, yet infectious influenza virus was required for responses. NA 79-93-specific T-hybridoma clones raised by immunization either with whole virus or with the synthetic peptide alone each responded to replicative virus and not to UV-inactivated virions. These data suggest that the NA 79-93 T-cell determinant which is commonly presented during an encounter with influenza virus in vivo is processed preferentially from NA synthesized within antigen-presenting cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898970      PMCID: PMC239806     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  The immune response of BALB/c mice to influenza hemagglutinin: commonality of the B cell and T cell repertoires and their relevance to antigenic drift.

Authors:  B C Barnett; C M Graham; D S Burt; J J Skehel; D B Thomas
Journal:  Eur J Immunol       Date:  1989-03       Impact factor: 5.532

2.  I-Ad-binding peptides derived from unrelated protein antigens share a common structural motif.

Authors:  A Sette; S Buus; S Colon; C Miles; H M Grey
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

3.  Structure of the catalytic and antigenic sites in influenza virus neuraminidase.

Authors:  P M Colman; J N Varghese; W G Laver
Journal:  Nature       Date:  1983 May 5-11       Impact factor: 49.962

4.  Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution.

Authors:  J N Varghese; W G Laver; P M Colman
Journal:  Nature       Date:  1983 May 5-11       Impact factor: 49.962

5.  Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses.

Authors:  G L Smith; J Z Levin; P Palese; B Moss
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

6.  Role of receptor-binding activity of the viral hemagglutinin molecule in the presentation of influenza virus antigens to helper T cells.

Authors:  L C Eisenlohr; W Gerhard; C J Hackett
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

7.  Antigen form influences induction and frequency of influenza-specific class I and class II MHC-restricted cytolytic T lymphocytes.

Authors:  L A Morrison; V L Braciale; T J Braciale
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

8.  Genetic control and fine specificity of the immune response to a synthetic peptide of influenza virus hemagglutinin.

Authors:  L E Brown; J M Murray; E M Anders; X L Tang; D O White; G W Tregear; D C Jackson
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

9.  Cells process exogenous proteins for recognition by cytotoxic T lymphocytes.

Authors:  J W Yewdell; J R Bennink; Y Hosaka
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

10.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

View more
  4 in total

Review 1.  Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.

Authors:  Laurence C Eisenlohr; Nancy Luckashenak; Sebastien Apcher; Michael A Miller; Gomathinayagam Sinnathamby
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

Review 2.  Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo.

Authors:  Suzanne L Epstein
Journal:  Am J Epidemiol       Date:  2018-12-01       Impact factor: 4.897

3.  Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle.

Authors:  Ki-Hye Kim; Zhuo Li; Noopur Bhatnagar; Jeeva Subbiah; Bo Ryoung Park; Chong Hyun Shin; Peter Pushko; Bao-Zhong Wang; Sang-Moo Kang
Journal:  PLoS Pathog       Date:  2022-08-25       Impact factor: 7.464

Review 4.  NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?

Authors:  Florian Krammer; Ron A M Fouchier; Maryna C Eichelberger; Richard J Webby; Kathryn Shaw-Saliba; Hongquan Wan; Patrick C Wilson; Richard W Compans; Ioanna Skountzou; Arnold S Monto
Journal:  mBio       Date:  2018-04-03       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.